evidencegaps
Primary study · included by 1 review

Neoadjuvant programmed cell death protein 1 inhibitors combined with chemotherapy in resectable non-small cell lung cancer: an open-label, multicenter, single-arm study.

Duan 2021 · Duan Hongtao, Wang Tianhu, Luo Zhilin, et al. · Translational lung cancer research · 2021

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Duan 2021 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.